0.00Open2.50Pre Close0 Volume4 Open Interest17.50Strike Price0.00Turnover142.24%IV14.09%PremiumDec 20, 2024Expiry Date0.04Intrinsic Value100Multiplier23DDays to Expiry2.46Extrinsic Value100Contract SizeAmericanOptions Type-0.4327Delta0.0633Gamma6.98Leverage Ratio-0.0526Theta-0.0057Rho-3.02Eff Leverage0.0172Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet